Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Research & Development: 2019-2024

Historic Research & Development for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $145.8 million.

  • Harmony Biosciences Holdings' Research & Development rose 116.50% to $55.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.3 million, marking a year-over-year increase of 23.23%. This contributed to the annual value of $145.8 million for FY2024, which is 91.72% up from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Research & Development of $145.8 million as of FY2024, which was up 91.72% from $76.1 million recorded in FY2023.
  • In the past 5 years, Harmony Biosciences Holdings' Research & Development registered a high of $145.8 million during FY2024, and its lowest value of $19.4 million during FY2020.
  • Over the past 3 years, Harmony Biosciences Holdings' median Research & Development value was $76.1 million (recorded in 2023), while the average stood at $97.6 million.
  • Its Research & Development has fluctuated over the past 5 years, first slumped by 72.06% in 2020, then surged by 133.43% in 2022.
  • Yearly analysis of 5 years shows Harmony Biosciences Holdings' Research & Development stood at $19.4 million in 2020, then spiked by 56.14% to $30.4 million in 2021, then spiked by 133.43% to $70.9 million in 2022, then increased by 7.30% to $76.1 million in 2023, then soared by 91.72% to $145.8 million in 2024.